Diagnostic test to predict responders to immunotherapy in case of cancer.
Total raised: $22M
Investors 5
| Date | Name | Website |
| - | Outsized V... | outsized.v... |
| - | Conor Fund... | conorfund.... |
| - | BXR Partne... | bxrgroup.c... |
| - | SPRIM Glob... | sprim.net |
| 18.03.2021 | Luminous V... | luminous.v... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 31.03.2021 | - | $14M | - |
| 13.02.2017 | - | $8M | - |
Mentions in press and media 2
| Date | Title | Description | Source |
| 31.03.2021 | Treos Bio Announces $14 Million Convertible Loan Note Financ... | Proceeds will fund Phase II clinical trials of PolyPEPI-1018, the Company’s off-the-shelf polypeptid... | marketscre... |
| 13.02.2017 | Treos Bio Completes $8M in Funding | Treos Bio, Ltd., a London, UK- and Bethesda, MD-based developer of precision cancer immunotherapies ... | finsmes.co... |